View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

Candel Therapeutics Reports Fourth Quarter and Full Year 2023 Financia...

Candel Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Highlights On track for topline data from CAN-2409 phase 3 in localized intermediate/high risk prostate cancer, expected in Q4 2024Results from ongoing, first-in-human, phase 1b clinical trial of CAN-3110, in recurrent high-grade glioma, published in NatureCatalyst-rich 2024 paves way for transformational year NEEDHAM, Mass., March 28, 2024 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing...

 PRESS RELEASE

Tevogen Bio Reports Series A-1 Preferred Stock Investment at $10 Conve...

Tevogen Bio Reports Series A-1 Preferred Stock Investment at $10 Conversion Price WARREN, N.J., March 28, 2024 (GLOBE NEWSWIRE) -- ('Tevogen Bio') (: ), a clinical-stage specialty immunotherapy biotech pioneer developing off-the-shelf, genetically unmodified T cell therapeutics in virology, oncology, and neurology, has entered into a securities purchase agreement with an existing investor pursuant to which the investor agreed to purchase shares of newly designated Series A-1 Preferred Stock of the Company in lieu of Series A Preferred Stock that the investor earlier agreed to purchase, f...

 PRESS RELEASE

Agile Therapeutics Reports Fourth Quarter & Full Year 2023 Financial R...

Agile Therapeutics Reports Fourth Quarter & Full Year 2023 Financial Results and Provides Corporate Update Full Year 2023 Net Revenue Increased 80% from 2022 While OPEX Decreased 33% Twirla Demand and Factory Sales Up 121% and 114% Respectively in 2023 vs 2022 Company Completes Pay-Off of Debt Facility in First Quarter 2024 Twirla Demand Expected to Rebound in First Quarter 2024 from Decreased Demand in Fourth Quarter 2023 Management to Host Conference Call Today, Thursday, March 28, 2024 at 8:30 a.m. ET PRINCETON, N.J., March 28, 2024 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Pi...

 PRESS RELEASE

AIM ImmunoTech to Present at the MedInvest Biotech & Pharma Investor C...

AIM ImmunoTech to Present at the MedInvest Biotech & Pharma Investor Conference Live webcast presentation on Wednesday, April 3rd at 1:35 PM ET OCALA, Fla., March 28, 2024 (GLOBE NEWSWIRE) -- (NYSE American: AIM) (“AIM” or the “Company”) today announced that of AIM ImmunoTech, will present at the being held in New York, N.Y., on Wednesday, April 3, 2024, at 1:35 PM ET. In addition to the presentation, management will be available to participate in one-on-one meetings with qualified members of the investor community who are registered to attend the conference. For more information ab...

 PRESS RELEASE

Microchip Technology Expands Its Serial SRAM Portfolio to Larger Densi...

Microchip Technology Expands Its Serial SRAM Portfolio to Larger Densities and Increased Speeds Product line offers a lower-cost alternative to parallel SRAM with up to 4 Mb density and 143 MHz SPI/SQI™ communications CHANDLER, Ariz., March 28, 2024 (GLOBE NEWSWIRE) -- To address a common customer need for bigger and faster SRAM, Microchip Technology (Nasdaq: MCHP) has expanded its product line to include larger densities of up to 4 Mb and increased Serial Peripheral Interface/Serial Quad I/O™ Interface (SPI/SQI™) speed to 143 MHz. The 2 Mb and 4 Mb devices are designed to provide a lo...

 PRESS RELEASE

Catalyst Pharmaceuticals Announces Support for the Inaugural Lambert-E...

Catalyst Pharmaceuticals Announces Support for the Inaugural Lambert-Eaton Myasthenic Syndrome (LEMS) Awareness Day CORAL GABLES, Fla., March 28, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst") (Nasdaq: CPRX), a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for patients living with rare and difficult-to-treat diseases, today announced its endorsement of the inaugural Lambert-Eaton myasthenic syndrome ("LEMS") Awareness Day. This landmark event, now officially observed a...

 PRESS RELEASE

EXL hosts virtual data and AI event

EXL hosts virtual data and AI event EXL’s AI in Action will showcase how enterprises are making a real impact using data and AI to drive business impact NEW YORK, March 28, 2024 (GLOBE NEWSWIRE) -- EXL [NASDAQ: EXLS], a leading data analytics, digital operations, and solutions company, announced its upcoming data and AI virtual event, AI in Action, scheduled for April 24 from 10:00 a.m. to 12:00 p.m. ET. The event promises to be an immersive experience, bringing together clients, prospects, and industry experts to explore the transformative power of data and AI at scale. Rohit Kapoor...

 PRESS RELEASE

Romande Energie Ventures presents its gems

Romande Energie SA / Key word(s): Miscellaneous Romande Energie Ventures presents its gems 28.03.2024 / 13:00 CET/CEST Dear Sir or Madam Please find attached copy of our press release: Contact for media representatives   Contact for Investor Relations (IR) Michèle Cassani   René Lauckner Spokesperson   Head of Group Treasury       Phone: +41 (0)21 802 95 67   Phone: +41 (0)21 802 95 24 Email: Email: End of Media Release Language: English Company: Romande Energie SA Rue de Lausanne 1110 Morges Switz...

 PRESS RELEASE

Laxxon Medical to Participate in 23rd Annual Needham Virtual Health Co...

Laxxon Medical to Participate in 23rd Annual Needham Virtual Health Conference New York, 03/28/2024 / 08:00, EST/EDT - EQS Newswire - Laxxon Medical NEW YORK, NY / ACCESSWIRE / March 28, 2024 / , a leading pharma-technology company pioneering a new generation of advanced pharmaceuticals, announced today their participation as a private company in the 23rd Annual Needham Virtual Healthcare Conference on April 8-11, 2024.Helmut Kerschbaumer, CEO/Chairman, and Alexander Ruckdaeschel, Chief Strategy Officer, will hold one-on-one meetings with institutional, private equity, and venture capital i...

 PRESS RELEASE

Romande Energie Ventures présente ses pépites

Romande Energie SA / Mot-clé(s) : Autres Romande Energie Ventures présente ses pépites 28.03.2024 / 13:00 CET/CEST Mesdames, Messieurs, Nous vous prions de bien vouloir trouver, ci-joint, le communiqué de presse intitulé : Contact MEDIAS   Contact IR - relations investisseurs Michèle Cassani   René Lauckner Porte-parole   Trésorier du Groupe       Tél. fixe: +41 (0)21 802 95 67   Tél. fixe : +41 (0)21 802 95 24 Email: Email: Fin du communiqué aux médias Langue : Français Entreprise : Romande Energie SA ...

 PRESS RELEASE

Xometry Introduces Enhanced Teamspace Collaboration Features To Furthe...

Xometry Introduces Enhanced Teamspace Collaboration Features To Further Expedite Order Management On Its AI-Powered Marketplace Enhanced Collaboration, Order Management Tools And Comprehensive Quote Summary Histories Help Expedite Procurement Within Enterprise Environments NORTH BETHESDA, Md., March 28, 2024 (GLOBE NEWSWIRE) -- Xometry Inc. (NASDAQ: XMTR), connecting enterprise buyers with suppliers of manufacturing services, today introduced enhanced features for its enterprise collaboration software designed to further expedite procurement on its marketplace. “We’re consistently ...

 PRESS RELEASE

Acrivon Therapeutics Reports Fourth Quarter and Full Year 2023 Financi...

Acrivon Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights WATERTOWN, Mass., March 28, 2024 (GLOBE NEWSWIRE) -- Acrivon Therapeutics, Inc. (“Acrivon” or “Acrivon Therapeutics”) (Nasdaq: ACRV), a clinical stage biopharmaceutical company developing precision oncology medicines that it matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proprietary proteomics-based patient responder identification platform, Acrivon Predictive Precision Proteomics (AP3), today reported financial results for the...

 PRESS RELEASE

BrainsWay Announces Positive Results in Late-Life Depression Post-Mark...

BrainsWay Announces Positive Results in Late-Life Depression Post-Marketing Analysis Data Published in Leading Peer-Reviewed Publication, Journal of Clinical Medicine JERUSALEM and BURLINGTON, Mass., March 28, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, announced positive results in a recently published post-marketing study of its Deep Transcranial Magnetic Stimulation (Deep TMS™) for the treatment of late-life depression. The data were high...

 PRESS RELEASE

Arcutis to Present at the 23rd Annual Needham Virtual Healthcare Confe...

Arcutis to Present at the 23rd Annual Needham Virtual Healthcare Conference WESTLAKE VILLAGE, Calif., March 28, 2024 (GLOBE NEWSWIRE) --  (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that Arcutis management will participate in the 23rd Annual Needham Virtual Healthcare Conference, taking place April 8-11, 2024. Details for the company’s participation are as follows:  Fireside Chat Date: Thursday, April 11, 2024 Fireside Chat Time: 2:15 pm EDT   The webcast for this conference may be access...

 PRESS RELEASE

4DMT Announces Update on Regulatory Interactions and Development Path ...

4DMT Announces Update on Regulatory Interactions and Development Path for 4D-710 for Treatment of Cystic Fibrosis Conducted initial pivotal study interactions with the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA); Company has clear registration path for 4D-710 for treatment of cystic fibrosis (CF) lung disease in people with CF (pwCF) who are ineligible for or cannot tolerate approved CF modulator therapies AEROW clinical trial Phase 2 Expansion Cohort dose selection and initiation expected in Q2 2024, with pivotal trial initiation anticipated in H2 2025Initi...

 PRESS RELEASE

Reviva to Present RECOVER Phase 3 Clinical Trial Data for Brilaroxazin...

Reviva to Present RECOVER Phase 3 Clinical Trial Data for Brilaroxazine in Schizophrenia at the SIRS 2024 Annual Meeting CUPERTINO, Calif., March 28, 2024 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), inflammatory and cardiometabolic diseases, today announced that Laxminarayan Bhat, Ph.D., Founder, President, and CEO of Reviva will be presenting at the 2024 Schizophrenia International Researc...

 PRESS RELEASE

Sofwave Medical to Participate in the Needham 23rd Annual Healthcare C...

Sofwave Medical to Participate in the Needham 23rd Annual Healthcare Conference SAN CLEMENTE, Calif., March 28, 2024 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices for practitioners worldwide, today announced that Louis Scafuri, Chief Executive Officer, and Assaf Korner, Chief Financial Officer, will provide a corporate update and participate in one-on-one investor meetings at the Needham 23rd Annual Healthcare Conference, to be held virtually from April 8-11, 2024. Needham 23rd Annual Healthcare Conference...

 PRESS RELEASE

Agrify Corporation Announces Turnkey Hydrocarbon Extraction Equipment ...

Agrify Corporation Announces Turnkey Hydrocarbon Extraction Equipment Contract with Connecticut-Based Company New England Edibles, dba SoundView TROY, Mich., March 28, 2024 (GLOBE NEWSWIRE) -- Agrify Corporation (Nasdaq: AGFY) (“Agrify” or the “Company”), a leading provider of innovative cultivation and extraction solutions for the cannabis industry, today announced the signing of a Turnkey Hydrocarbon Extraction and Lab Equipment Package with New England Edibles, dba SoundView, (“SoundView” or the “Customer”), a licensed operator based in Bristol, CT. SoundView has purchased Agrify’s Tu...

 PRESS RELEASE

Enphase Energy Launches IQ8P Microinverters for High-Powered Solar Mod...

Enphase Energy Launches IQ8P Microinverters for High-Powered Solar Modules in Thailand and the Philippines FREMONT, Calif., March 28, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, today announced that it has started shipping IQ8P™ Microinverters, with peak output AC power of 480 W, for residential and commercial applications in Thailand and the Philippines to support newer high-powered solar modules. IQ8™ Microinverters are designed to maximize energy production and can manag...

 PRESS RELEASE

Linkage Global Inc Subsidiary to Offer Cross-Border E-commerce Store O...

Linkage Global Inc Subsidiary to Offer Cross-Border E-commerce Store Operation Services, Unleashing Global Growth Potential Tokyo, Japan, March 28, 2024 (GLOBE NEWSWIRE) -- Linkage Global Inc (the “Company” or “Linkage”), (NASDAQ: LGCB), a cross-border e-commerce integrated service company headquartered in Japan, today announced that Fujian Chuancheng Digital Technology Limited (“Fujian Chuancheng”), a wholly owned subsidiary of the Company, has launched cross-border e-commerce store operation services, which include operating and maintaining the customers’ third-party online stores on Am...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch